ClinConnect ClinConnect Logo
Search / Trial NCT06451367

Cardiovascular and Endocrine Response to Muscular Training Program of Young Soccer Players Aged 14-18 Years

Launched by HÔPITAL FRIBOURGEOIS · Jun 10, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a specific muscular training program affects the heart and hormone levels in young soccer players aged 14 to 18. The researchers want to understand how this training may improve athletes' overall health, reduce the risk of injuries, and enhance their performance in soccer. The study will last 12 weeks and will closely monitor the players to ensure they are not overtraining, which could lead to negative health effects.

To participate in the study, players need to be part of a soccer training program, be between 14 and 18 years old, and have a normal body weight. They should not have had any serious injuries in the last six months, be taking certain medications, or using anabolic supplements. Both participants and their parents or guardians will need to agree to share important health information during the study to keep everyone informed. This trial aims to create better training guidelines for young athletes to help them stay healthy and perform their best in soccer.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Engaging in a football training program.
  • No history of injuries in the last 6 months requiring surgical intervention.
  • No intake of anabolic supplements.
  • Age 14-18 years old.
  • Normal BMI (18.5 - 24.9 kg/m²).
  • Parents and participants must consent to receive all pertinent information discovered during the study, such as potential cardiovascular diseases or hormonal disorders.
  • Participants must also consent to the sharing of certain private information with their parents or legal guardians. This includes information regarding cannabis use, as well as the consumption of anabolic steroids and other controlled substances. This additional consent ensures transparency and openness in sharing relevant health-related information with parents or legal guardians, particularly for participants under 18 years of age.
  • For participants under the age of 18, parental consent or consent from a legal guardian is mandatory in addition to the participant's consent. This ensures that minors have parental approval to take part in the study.
  • All participants, regardless of age, must provide their voluntary consent to participate in the study. For participants under the age of 18, consent from one of their parents or legal guardians is also required in addition to the participant's consent.
  • Exclusion Criteria:
  • Engaging in other supplemental individual exercise programs.
  • Being a smoker (\>1 cigarette/week).
  • Using any medication at the time of testing.
  • Having any disease.

About Hôpital Fribourgeois

Hôpital Fribourgeois is a leading healthcare institution located in Fribourg, Switzerland, dedicated to providing high-quality medical care and advancing clinical research. As a sponsor of clinical trials, Hôpital Fribourgeois is committed to exploring innovative treatments and therapies that enhance patient outcomes. The hospital's multidisciplinary team of experienced researchers and healthcare professionals collaborates closely with academic and industry partners to ensure the rigorous design and ethical conduct of clinical studies. Through its research initiatives, Hôpital Fribourgeois aims to contribute significantly to medical knowledge and improve healthcare practices both locally and globally.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported